These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18186043)

  • 1. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
    Hossainy S; Prabhu S
    J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
    Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating.
    Zhao HQ; Jayasinghe D; Hossainy S; Schwartz LB
    J Biomed Mater Res A; 2012 Jan; 100(1):120-4. PubMed ID: 21997889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
    Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
    Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
    Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y
    Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xience V everolimus-eluting coronary stent.
    Kukreja N; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model.
    Prunotto M; Vignolini C; Lolli V; Black A; Gaggianesi S; Santarelli A; Galloni M
    J Biomed Mater Res A; 2009 Mar; 88(4):872-9. PubMed ID: 18360883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating.
    Sirianni RW; Jang EH; Miller KM; Saltzman WM
    J Control Release; 2010 Mar; 142(3):474-82. PubMed ID: 19958804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of degradation and drug release from a biodegradable stent coating.
    Prabhu S; Hossainy S
    J Biomed Mater Res A; 2007 Mar; 80(3):732-41. PubMed ID: 17167794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of drug coating on drug eluting stents].
    Luo LL; Wang GX; Yin TY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy.
    Papafaklis MI; Chatzizisis YS; Naka KK; Giannoglou GD; Michalis LK
    Pharmacol Ther; 2012 Apr; 134(1):43-53. PubMed ID: 22212618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.